Allocetra
Phase 2- Indications
- Sepsis, Organ failure, Solid tumors
Company intelligence / Profile preview
Ornim Medical
Kefar Sava, Center District, Israelfinder.startupnationcentral.org ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
The company's c-FLOW™ monitor has demonstrated the ability to identify the exact time when cerebral blood flow is reestablished and hemispheric asymmetries of flow normalized in acute stroke patients, allowing clinicians to determine if their approach in care or therapy is immediately effective[5].
- Therapeutic areas
- OtherNeurology
- Modalities
- Non-invasive monitoring devices
- Industry
- Physiological Monitoring
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Beth Israel Deaconess Medical Center[1]
Beyond the preview
Go deeper on Ornim Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ornim Medical.